ALT5 Sigma (NASDAQ:AIFC – Get Free Report) and Mentor Capital (OTCMKTS:MNTR – Get Free Report) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.
Earnings & Valuation
This table compares ALT5 Sigma and Mentor Capital”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| ALT5 Sigma | $24.84 million | 3.68 | -$344.51 million | N/A | N/A |
| Mentor Capital | $170,000.00 | 4.69 | -$570,000.00 | ($0.03) | -1.23 |
Institutional and Insider Ownership
6.3% of ALT5 Sigma shares are held by institutional investors. 0.2% of ALT5 Sigma shares are held by company insiders. Comparatively, 23.7% of Mentor Capital shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Volatility & Risk
ALT5 Sigma has a beta of 1.71, indicating that its share price is 71% more volatile than the S&P 500. Comparatively, Mentor Capital has a beta of -0.84, indicating that its share price is 184% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of current recommendations and price targets for ALT5 Sigma and Mentor Capital, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ALT5 Sigma | 1 | 0 | 0 | 0 | 1.00 |
| Mentor Capital | 0 | 0 | 0 | 0 | 0.00 |
Profitability
This table compares ALT5 Sigma and Mentor Capital’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ALT5 Sigma | -2,483.94% | -68.25% | -62.43% |
| Mentor Capital | -261.84% | -23.05% | -18.62% |
Summary
Mentor Capital beats ALT5 Sigma on 6 of the 10 factors compared between the two stocks.
About ALT5 Sigma
ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.
About Mentor Capital
Mentor Capital, Inc. is a private equity firm specializing in acquisitions and emerging growth investments. The firm provides passive equity funding and liquidity to smaller companies and owners in the medical, marijuana and social use cannabis companies. It invests in shelf IPO’s and public and private companies and seeks to provide public market access to owners of small private companies. The firm specializes in pre-IPO investments in Cannabis companies. It seeks to invest in energy sector of oil and gas, coal, uranium. In case of shelf IPO’s, the firm prefers to invest in companies with sales greater than $40 million. It prefers to take significant position in its portfolio companies. The firm invests only in companies that have earnings. Mentor Capital, Inc. was founded in 1985 and is based in Plano, Texas.
Receive News & Ratings for ALT5 Sigma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALT5 Sigma and related companies with MarketBeat.com's FREE daily email newsletter.
